Amy  Delson, AIA is a long-term breast cancer survivor, committed research advocate, and laboratory architect with the firm she founded, Strategic Facilities Planning.  Amy has  translated her professional skills in collaborating with scientists and healthcare providers to her role as a member of the i-SPY2 Biomarker Working Group. She attended Project LEAD Institute, reviewed for DOD CDMRP, observed  for CBCRP, is a Komen Advocate in Science and UCSF Breast Science Advocacy Core member, and speaks on the patient perspective on precision medicine.